gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:bfsLayer
|
4
|
gptkbp:bfsParent
|
gptkb:Contagion
|
gptkbp:case_types
|
8098
|
gptkbp:casualties
|
774
|
gptkbp:caused_by
|
gptkb:SARS_coronavirus
|
gptkbp:community_impact
|
social distancing measures
increased hygiene practices
|
gptkbp:complications
|
gptkb:healthcare_organization
acute respiratory distress syndrome
multi-organ failure
|
gptkbp:defense
|
global alert
|
gptkbp:discovered_by
|
gptkb:2002
|
gptkbp:economic_impact
|
economic downturn
|
gptkbp:healthcare
|
gptkb:significant
|
https://www.w3.org/2000/01/rdf-schema#label
|
SARS
|
gptkbp:involved_countries
|
29
|
gptkbp:is_protected_by
|
quarantine
personal protective equipment
travel restrictions
|
gptkbp:is_recognized_by
|
gptkb:China
|
gptkbp:is_vulnerable_to
|
no approved vaccine
|
gptkbp:legacy
|
public awareness campaigns
improved pandemic preparedness
research funding for infectious diseases
enhanced global cooperation
increased surveillance of coronaviruses
|
gptkbp:notable_figures
|
gptkb:Dr._Carlo_Urbani
gptkb:Dr._David_Heymann
gptkb:Dr._Margaret_Chan
gptkb:Dr._Zhong_Nanshan
gptkb:Dr._Julie_Gerberding
|
gptkbp:population_trend
|
contained
|
gptkbp:propagation_method
|
respiratory droplets
|
gptkbp:related_to
|
gptkb:COVID-19
|
gptkbp:research
|
vaccine development efforts
|
gptkbp:research_focus
|
coronaviruses
|
gptkbp:reservoir
|
gptkb:civet_cats
bats
|
gptkbp:seating_capacity
|
travel advisories
|
gptkbp:side_effect
|
strain on healthcare systems
|
gptkbp:social_responsibility
|
PCR test
serological test
|
gptkbp:symptoms
|
headache
muscle pain
cough
fever
sore throat
diarrhea
chills
shortness of breath
|
gptkbp:treatment
|
supportive care
antiviral medications
|
gptkbp:year
|
gptkb:2003
|